Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Chair Berman and Members
Pricing may be promotional and may change during enrollment or renewal
On Monday, it announced earnings from the last quarter of 2025 after a whirlwind month that raised questions about the regulatory risks of the companys compounding model and the threat of an investigation
Original price was: $105.00.Current price is: $85.00
Our experts can guide you through the options, ensuring you find the perfect IV therapy for your nutritional needs
Comprehensive analysis of the expression and prognosis for TDO2 in breast cancer
US$ 20.31
US$ 21.60
US$ 20.35
US$ 27.18
US$ 27.05
US$ 28.31
